TY - JOUR AU - Kacperski, J. AU - Bazarsky, A. PY - 2017 DA - 2017// TI - New developments in the prophylactic drug treatment of pediatric migraine: what is new in 2017 and where does it leave us? JO - Curr Pain Headache Rep VL - 21 UR - https://doi.org/10.1007/s11916-017-0638-4 DO - 10.1007/s11916-017-0638-4 ID - Kacperski2017 ER - TY - JOUR AU - Powers, S. W. AU - Patton, S. R. AU - Hommel, K. A. AU - Hershey, A. D. PY - 2004 DA - 2004// TI - Quality of life in paediatric migraine: Characterization of age-related effects using Peds QL 4.0 JO - Cephalalgia VL - 24 UR - https://doi.org/10.1111/j.1468-2982.2004.00652.x DO - 10.1111/j.1468-2982.2004.00652.x ID - Powers2004 ER - TY - JOUR PY - 2018 DA - 2018// TI - The International Classification of Headache Disorders, 3rd edition JO - Cephalalgia VL - 38 UR - https://doi.org/10.1177/0333102417738202 DO - 10.1177/0333102417738202 ID - ref3 ER - TY - JOUR AU - Termine, C. AU - Ozge, A. AU - Antonacci, F. AU - Natriashvili, S. AU - Guidetti, V. AU - Wober-Bingol, C. PY - 2011 DA - 2011// TI - Overview of diagnosis and management of pediatric headache. Part II: therapeutic management JO - J Headache Pain VL - 12 UR - https://doi.org/10.1007/s10194-010-0256-6 DO - 10.1007/s10194-010-0256-6 ID - Termine2011 ER - TY - JOUR AU - Guidetti, V. AU - Galli, F. PY - 1998 DA - 1998// TI - Evolution of headache in childhood and adolescents: an 8-year follow up JO - Cephalalgia VL - 18 UR - https://doi.org/10.1046/j.1468-2982.1998.1807449.x DO - 10.1046/j.1468-2982.1998.1807449.x ID - Guidetti1998 ER - TY - JOUR AU - Orr, S. L. AU - Kabbouche, M. A. AU - O'Brien, H. L. PY - 2018 DA - 2018// TI - Paediatric migraine: evidence-based management and future directions JO - Nat Rev Neurol VL - 14 UR - https://doi.org/10.1038/s41582-018-0042-7 DO - 10.1038/s41582-018-0042-7 ID - Orr2018 ER - TY - JOUR AU - El-Chammas, K. AU - Keyes, J. AU - Thompson, N. AU - Vijayakumar, J. AU - Becher, D. AU - Jackson, J. L. PY - 2013 DA - 2013// TI - A comparative effectiveness meta-analysis of drugs for the prophylaxis of pediatric migraine headache JO - JAMA Pediatr VL - 167 UR - https://doi.org/10.1001/jamapediatrics.2013.508 DO - 10.1001/jamapediatrics.2013.508 ID - El-Chammas2013 ER - TY - JOUR AU - Kacperski, J. AU - Kabbouche, M. A. AU - O’Brien, H. L. AU - Weberding, J. L. PY - 2016 DA - 2016// TI - The optimal management of headaches in children and adolescents JO - Ther Adv Neurol Disord VL - 9 UR - https://doi.org/10.1177/1756285615616586 DO - 10.1177/1756285615616586 ID - Kacperski2016 ER - TY - JOUR AU - Powers, S. W. AU - Coffey, C. S. AU - Chamberlin, L. A. AU - Ecklund, D. J. AU - Klingner, E. A. AU - Yankey, J. W. PY - 2017 DA - 2017// TI - Trial of amitriptyline, topiramate, and place- Bo for pediatric migraine JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1610384 DO - 10.1056/NEJMoa1610384 ID - Powers2017 ER - TY - JOUR AU - Evers, S. AU - Marziniak, M. AU - Frese, A. AU - Gralow, I. PY - 2009 DA - 2009// TI - Placebo efficacy in childhood and adolescence migraine: an analysis of double blind and placebo-controlled studies JO - Cephalalgia. VL - 29 UR - https://doi.org/10.1111/j.1468-2982.2008.01752.x DO - 10.1111/j.1468-2982.2008.01752.x ID - Evers2009 ER - TY - JOUR AU - Sangermani, R. AU - Boncimino, A. PY - 2017 DA - 2017// TI - The use of nutraceutics in children's and adolescent's headache JO - Neurol Sci VL - 38 UR - https://doi.org/10.1007/s10072-017-2896-7 DO - 10.1007/s10072-017-2896-7 ID - Sangermani2017 ER - TY - JOUR PY - 2013 DA - 2013// TI - The International Classification of Headache Disorders, 3rd edition (beta version) JO - Cephalalgia VL - 33 UR - https://doi.org/10.1177/0333102413485658 DO - 10.1177/0333102413485658 ID - ref12 ER - TY - JOUR AU - Grinnon, S. T. AU - Miller, K. AU - Marler, J. R. AU - Lu, Y. AU - Stout, A. AU - Odenkirchen, J. AU - Kunitz, S. PY - 2012 DA - 2012// TI - National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods JO - Clin Trials VL - 9 UR - https://doi.org/10.1177/1740774512438980 DO - 10.1177/1740774512438980 ID - Grinnon2012 ER - TY - JOUR AU - Holland, S. AU - Silberstein, S. D. AU - Freitag, F. AU - Dodick, D. W. AU - Argoff, C. AU - Ashman, E. PY - 2012 DA - 2012// TI - Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society JO - Neurology. VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182535d0c DO - 10.1212/WNL.0b013e3182535d0c ID - Holland2012 ER - TY - JOUR AU - Greco, R. AU - Siani, F. AU - Demartini, C. PY - 2016 DA - 2016// TI - Andrographis paniculata shows anti-nociceptive effects in an animal model of sensory hypersensitivity associated with migraine JO - Functional Neurology VL - 31 UR - https://doi.org/10.11138/FNeur/2016.31.1.053 DO - 10.11138/FNeur/2016.31.1.053 ID - Greco2016 ER - TY - STD TI - Società Italiana per lo Studio delle Cefalee. Linee Guida per la diagnosi e la terapia delle cefalee primarie 2011. ID - ref16 ER - TY - STD TI - Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2015, Issue 4. Art. No.: CD002286. DOI: https://doi.org/10.1002/14651858.CD002286.pub3. ID - ref17 ER - TY - STD TI - Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM. The anti-inflammatory natural product parthenolide from the medicinal herb feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 2001;8(8):759–766. PubMed PMID: 11514225 UR - https://www.ncbi.nlm.nih.gov/pubmed/11514225 ID - ref18 ER - TY - JOUR AU - Tassorelli, C. AU - Greco, R. AU - Morazzoni, P. AU - Riva, A. AU - Sandrini, G. AU - Nappi, G. PY - 2005 DA - 2005// TI - Parthenolide is the component of Tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine JO - Cephalalgia: An International Journal of Headache VL - 25 UR - https://doi.org/10.1111/j.1468-2982.2005.00915.x DO - 10.1111/j.1468-2982.2005.00915.x ID - Tassorelli2005 ER - TY - JOUR AU - Materazzi, S. AU - Benemei, S. AU - Fusi, C. PY - 2013 DA - 2013// TI - Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting TRPA1 channel JO - Pain. VL - 154 UR - https://doi.org/10.1016/j.pain.2013.08.002 DO - 10.1016/j.pain.2013.08.002 ID - Materazzi2013 ER - TY - JOUR AU - Daniel, O. AU - Mauskop, A. PY - 2016 DA - 2016// TI - Nutraceuticals in acute and prophylactic treatment of migraine JO - Curr Treat Options Neurol VL - 18 UR - https://doi.org/10.1007/s11940-016-0398-1 DO - 10.1007/s11940-016-0398-1 ID - Daniel2016 ER - TY - JOUR AU - Taylor, F. R. PY - 2011 DA - 2011// TI - Nutraceuticals and headache: the biological basis JO - Headache. VL - 51 UR - https://doi.org/10.1111/j.1526-4610.2011.01847.x DO - 10.1111/j.1526-4610.2011.01847.x ID - Taylor2011 ER - TY - STD TI - Cevoli S, Favoni V, Cortelli P. Energy metabolism impairment in migraine. Curr Med Chem. 2018. https://doi.org/10.2174/0929867325666180622154411 [Epub ahead of print]. ID - ref23 ER - TY - JOUR AU - Markley, H. G. PY - 2012 DA - 2012// TI - CoEnzyme Q10 and riboflavin: the mitochondrial connection JO - Headache. VL - 52 UR - https://doi.org/10.1111/j.1526-4610.2012.02233.x DO - 10.1111/j.1526-4610.2012.02233.x ID - Markley2012 ER - TY - JOUR AU - Sándor, P. S. AU - Clemente, L. AU - Coppola, G. AU - Saenger, U. AU - Fumal, A. AU - Magis, D. AU - Seidel, L. AU - Agosti, R. M. AU - Schoenen, J. PY - 2005 DA - 2005// TI - Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial JO - Neurology. VL - 64 UR - https://doi.org/10.1212/01.WNL.0000151975.03598.ED DO - 10.1212/01.WNL.0000151975.03598.ED ID - Sándor2005 ER - TY - JOUR AU - Orr, S. L. PY - 2018 DA - 2018// TI - The evidence for the role of nutraceuticals in the Management of Pediatric Migraine: a review JO - Curr Pain Headache Rep VL - 22 UR - https://doi.org/10.1007/s11916-018-0692-6 DO - 10.1007/s11916-018-0692-6 ID - Orr2018 ER - TY - JOUR AU - Miles, M. V. AU - Morrison, J. A. AU - Horn, P. S. AU - Tang, P. H. AU - Pesce, A. J. PY - 2004 DA - 2004// TI - Coenzyme Q10 changes are associated with metabolic syndrome JO - Clin Chim Acta VL - 344 UR - https://doi.org/10.1016/j.cccn.2004.02.016 DO - 10.1016/j.cccn.2004.02.016 ID - Miles2004 ER - TY - JOUR AU - Sun-Edelstein, C. AU - Mauskop, A. PY - 2009 DA - 2009// TI - Role of magnesium in the pathogenesis and treatment of migraine JO - Expert Rev Neurother VL - 9 UR - https://doi.org/10.1586/14737175.9.3.369 DO - 10.1586/14737175.9.3.369 ID - Sun-Edelstein2009 ER - TY - JOUR AU - Akbar, S. PY - 2011 DA - 2011// TI - Andrographis paniculata: a review of pharmacological activities and clinical effects JO - Altern Med Rev VL - 16 ID - Akbar2011 ER - TY - JOUR AU - Blume, H. K. PY - 2017 DA - 2017// TI - Childhood headache: a brief review JO - Pediatr Ann VL - 46 UR - https://doi.org/10.3928/19382359-20170321-02 DO - 10.3928/19382359-20170321-02 ID - Blume2017 ER - TY - JOUR AU - Hershey, A. D. AU - Powers, S. W. AU - Coffey, C. S. PY - 2013 DA - 2013// TI - Childhood and adolescent migraine prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, Topiramate and placebo in the prevention of childhood and adolescent migraine JO - Headache. VL - 53 UR - https://doi.org/10.1111/head.12105 DO - 10.1111/head.12105 ID - Hershey2013 ER -